N.M. Admin. Code § 1.7.8.13

Current through Register Vol. 35, No. 19, October 8, 2024

Section 1.7.8.13 - DRUG TESTS

A. The initial and confirmatory drug tests shall be performed by a state licensed laboratory in accordance with the substance abuse and mental health services administration or the college of American pathologists in forensic urine drug testing. The laboratory shall have the capability of performing initial and confirmatory tests for each drug or metabolite for which service is offered.

B. The following initial cutoff concentrations shall be used when screening specimens on the initial drug tests to determine whether they are negative for these seven drugs or classes of drugs.

(1) Marijuana metabolites 50 (ng/ml)

(2) Cocaine metabolites 150 (ng/ml)

(3) Opiate metabolites 2,000 (ng/ml)

(4) 6-Acetylmorphine 10 (ng/ml)

(5) Phencyclidine (PCP) 25 (ng/ml)

(6) Amphetamines 500 (ng/ml)

(7) MDMA 500 (ng/ml)

C. All specimens identified as positive on the initial drug test, shall be confirmed by the laboratory at the cutoff concentration listed below for each drug. All confirmations shall be by quantitative analysis:

(1) Marijuana metabolite - Delta - 9-tetrahydrocannabinol - 9-carboxylic acid (THCA) 15 (ng/ml)

(2) Cocaine metabolite - Benzoylecgonine 100 (ng/ml)

(3)Opiates:

(a) Morphine 2,000 (ng/ml)

(b) Codeine 2,000 (ng/ml)

(4) 6-Acetylmorphine 10 (ng/ml)

(5) Phencyclidine (PCP) 25 (ng/ml)

(6)Amphetamines:

(a) Amphetamine 250 (ng/ml)

(b) Methamphetamine ¹ 250 (ng/ml)

(7) MDMA (Methylenedioxymethamphetemine) 250 (ng/ml)

(a) MDA (Methylenedioxyamphetamine) 250 (ng/ml)

(b) MDEA (Methylenedioxyethylamphetamine) 250 (ng/ml)

(8)¹To be reported as positive for methamphetamine, a specimen must also contain amphetamine at a concentration equal to or greater than 100 ng/ml.

D. The laboratory shall report as negative all specimens that are negative on the initial test or negative on the confirmatory test. Only specimens reported as positive on the confirmatory test shall be reported positive for a specific drug.

E. The laboratory shall retain and place those specimens confirmed positive in properly secured long-term frozen storage for at least 365 calendar days. An agency may request the laboratory to retain the specimen for an additional period of time. If the laboratory does not receive a request to retain the specimen during the initial 365 calendar day period, the specimen may be discarded.

N.M. Admin. Code § 1.7.8.13

1.7.8.13 NMAC - Rp, 1.7.8.13 NMAC, 2/12/2010; A/E, 10/1/2010; Re-pr, 12/1/2010